Company Filing History:
Years Active: 2015-2020
Title: Laura Bover: Innovator in Antibody Research
Introduction
Laura Bover is a prominent inventor based in Pearland, TX (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target the OX40 receptor. With a total of 6 patents to her name, her work is paving the way for advancements in therapeutic applications.
Latest Patents
One of Laura Bover's latest patents focuses on Anti-OX40 antibodies and methods of using the same. This patent discloses human antibodies, preferably recombinant human antibodies, both humanized and chimeric, which specifically bind to the human OX40 receptor. The preferred antibodies exhibit high affinity for the OX40 receptor and are capable of activating the receptor both in vitro and in vivo. These antibodies can be full-length or antigen-binding portions, and they are useful for modulating receptor activity in human subjects suffering from disorders where OX40 activity is detrimental. The patent also includes nucleic acids, vectors, and host cells for expressing the recombinant human antibodies, along with methods for synthesizing these antibodies.
Career Highlights
Laura Bover is affiliated with the University of Texas System, where she continues her research and development in antibody technology. Her innovative work has garnered attention in the scientific community, contributing to the understanding of immune modulation.
Collaborations
Some of her notable coworkers include Yong-Jun Liu and Kui Shin Voo, who collaborate with her on various research projects.
Conclusion
Laura Bover's contributions to antibody research, particularly in the area of OX40 receptor modulation, highlight her role as a leading inventor in biotechnology. Her patents reflect her commitment to advancing medical science and improving therapeutic options for patients.